论文信息 - Phase I study of CNF1010 (lipid formulation of 17-(allylamino)-17-demethoxygeldanamycin: 17-AAG) in patients with advanced solid tumors. - 字舞流文

Phase I study of CNF1010 (lipid formulation of 17-(allylamino)-17-demethoxygeldanamycin: 17-AAG) in patients with advanced solid tumors.

D. V. Von Hoff | M. Saif | C. Erlichman | D. Toft | F. Burrows | T. Dragovich | D. Mendelson | G. Timony | R. D. De Jager | C. Padgett